IDTA Stock Overview
IDenta Corp. operates as a detection and forensic science company.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
IDenta Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.22 |
| 52 Week High | US$0.50 |
| 52 Week Low | US$0.10 |
| Beta | 1.74 |
| 1 Month Change | 67.18% |
| 3 Month Change | 48.97% |
| 1 Year Change | -71.00% |
| 3 Year Change | -87.98% |
| 5 Year Change | 8.75% |
| Change since IPO | -97.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| IDTA | US Electronic | US Market | |
|---|---|---|---|
| 7D | 8.8% | 1.1% | 1.2% |
| 1Y | -71.0% | 21.5% | 24.9% |
Return vs Industry: IDTA underperformed the US Electronic industry which returned 22.3% over the past year.
Return vs Market: IDTA underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| IDTA volatility | |
|---|---|
| IDTA Average Weekly Movement | n/a |
| Electronic Industry Average Movement | 6.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: IDTA's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine IDTA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | n/a | Amichai Glattstein | www.identa-corp.com |
IDenta Corp. operates as a detection and forensic science company. The company offers drug, explosives, bullet-hole testing, and phenolphthalein blood detection kits; aero chamber sniffer; and FerroPrint testing products. It provides its solutions to law enforcement, military, and government agencies, as well as other organizations that deal in fighting illicit drugs and terrorist threats.
IDenta Corp. Fundamentals Summary
| IDTA fundamental statistics | |
|---|---|
| Market cap | US$879.92k |
| Earnings (TTM) | US$162.71k |
| Revenue (TTM) | US$1.34m |
5.4x
P/E Ratio0.7x
P/S RatioIs IDTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IDTA income statement (TTM) | |
|---|---|
| Revenue | US$1.34m |
| Cost of Revenue | US$355.15k |
| Gross Profit | US$983.60k |
| Other Expenses | US$820.89k |
| Earnings | US$162.71k |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.04 |
| Gross Margin | 73.47% |
| Net Profit Margin | 12.15% |
| Debt/Equity Ratio | 97.4% |
How did IDTA perform over the long term?
See historical performance and comparison